These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 18345405)

  • 1. [Metformin and AMPK: an old drug and a new enzyme in the context of metabolic syndrome].
    Santomauro Júnior AC; Ugolini MR; Santomauro AT; Souto RP
    Arq Bras Endocrinol Metabol; 2008 Feb; 52(1):120-5. PubMed ID: 18345405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMP activated protein kinase: a next generation target for total metabolic control.
    Misra P
    Expert Opin Ther Targets; 2008 Jan; 12(1):91-100. PubMed ID: 18076373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes.
    Musi N; Hirshman MF; Nygren J; Svanfeldt M; Bavenholm P; Rooyackers O; Zhou G; Williamson JM; Ljunqvist O; Efendic S; Moller DE; Thorell A; Goodyear LJ
    Diabetes; 2002 Jul; 51(7):2074-81. PubMed ID: 12086935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMPK: an emerging drug target for diabetes and the metabolic syndrome.
    Zhang BB; Zhou G; Li C
    Cell Metab; 2009 May; 9(5):407-16. PubMed ID: 19416711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Regulation of energy metabolism by AMPK: a novel therapeutic approach for the treatment of metabolic and cardiovascular diseases].
    Foretz M; Taleux N; Guigas B; Horman S; Beauloye C; Andreelli F; Bertrand L; Viollet B
    Med Sci (Paris); 2006 Apr; 22(4):381-8. PubMed ID: 16597407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of AMP-activated protein kinase in mechanism of metformin action.
    Zhou G; Myers R; Li Y; Chen Y; Shen X; Fenyk-Melody J; Wu M; Ventre J; Doebber T; Fujii N; Musi N; Hirshman MF; Goodyear LJ; Moller DE
    J Clin Invest; 2001 Oct; 108(8):1167-74. PubMed ID: 11602624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin promotes irisin release from murine skeletal muscle independently of AMP-activated protein kinase activation.
    Li DJ; Huang F; Lu WJ; Jiang GJ; Deng YP; Shen FM
    Acta Physiol (Oxf); 2015 Mar; 213(3):711-21. PubMed ID: 25382002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin: from mechanisms of action to therapies.
    Foretz M; Guigas B; Bertrand L; Pollak M; Viollet B
    Cell Metab; 2014 Dec; 20(6):953-66. PubMed ID: 25456737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of AMPK in pancreatic beta cell function.
    Fu A; Eberhard CE; Screaton RA
    Mol Cell Endocrinol; 2013 Feb; 366(2):127-34. PubMed ID: 22766107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting AMPK: From Ancient Drugs to New Small-Molecule Activators.
    Guigas B; Viollet B
    Exp Suppl; 2016; 107():327-350. PubMed ID: 27812986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMPK/Mitochondria in Metabolic Diseases.
    Bullon P; Marin-Aguilar F; Roman-Malo L
    Exp Suppl; 2016; 107():129-152. PubMed ID: 27812979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular Energy Sensing and Metabolism-Implications for Treating Diabetes: The 2017 Outstanding Scientific Achievement Award Lecture.
    Steinberg GR
    Diabetes; 2018 Feb; 67(2):169-179. PubMed ID: 29358486
    [No Abstract]   [Full Text] [Related]  

  • 13. AMP-activated protein kinase is activated in adipose tissue of individuals with type 2 diabetes treated with metformin: a randomised glycaemia-controlled crossover study.
    Boyle JG; Logan PJ; Jones GC; Small M; Sattar N; Connell JM; Cleland SJ; Salt IP
    Diabetologia; 2011 Jul; 54(7):1799-809. PubMed ID: 21455728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin improves atypical protein kinase C activation by insulin and phosphatidylinositol-3,4,5-(PO4)3 in muscle of diabetic subjects.
    Luna V; Casauban L; Sajan MP; Gomez-Daspet J; Powe JL; Miura A; Rivas J; Standaert ML; Farese RV
    Diabetologia; 2006 Feb; 49(2):375-82. PubMed ID: 16395615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetic variation and metformin response.
    Chen S; Zhou J; Xi M; Jia Y; Wong Y; Zhao J; Ding L; Zhang J; Wen A
    Curr Drug Metab; 2013 Dec; 14(10):1070-82. PubMed ID: 24329113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMP-activated protein kinase: a target for old drugs against diabetes and cancer.
    Russo GL; Russo M; Ungaro P
    Biochem Pharmacol; 2013 Aug; 86(3):339-50. PubMed ID: 23747347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanisms of action of metformin.
    Rena G; Hardie DG; Pearson ER
    Diabetologia; 2017 Sep; 60(9):1577-1585. PubMed ID: 28776086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A positive feedback loop between AMPK and GDF15 promotes metformin antidiabetic effects.
    Aguilar-Recarte D; Barroso E; Zhang M; Rada P; Pizarro-Delgado J; Peña L; Palomer X; Valverde ÁM; Wahli W; Vázquez-Carrera M
    Pharmacol Res; 2023 Jan; 187():106578. PubMed ID: 36435271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An energetic tale of AMPK-independent effects of metformin.
    Miller RA; Birnbaum MJ
    J Clin Invest; 2010 Jul; 120(7):2267-70. PubMed ID: 20577046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin; an old antidiabetic drug with new potentials in bone disorders.
    Bahrambeigi S; Yousefi B; Rahimi M; Shafiei-Irannejad V
    Biomed Pharmacother; 2019 Jan; 109():1593-1601. PubMed ID: 30551413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.